Back to search
FDAFDA · Food and drugs·Recall number D-0840-2018

Piperacillin and Tazobactam for Injection, USP 4.5 gram/vial* 10-count Single Use Vials per carton, Rx only, Mfg. by: Hospira Healthcare India Pvt. Ltd. Irungattukottai-602 105, India Mfg. for: Apotex Corp. Weston, FL 33326. NDC 60505-0688-4

Published May 23, 2018 · Recall initiated: May 8, 2018

Summary

FDA records drug Class I recall D-0840-2018, published May 23, 2018 and initiated May 8, 2018. Recalling firm: Apotex Inc.; Status: Terminated; Reported quantity: 13453 vials; Lot: Lots: 502H001 Exp. 01/2019; 502H003, 502H004, 502H005, Exp. 04/2019; 502H009, 502H012, Exp. 05/2019. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: High Levels of Impurities Resulting in Decrease Potency

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apotex Inc.
Distributor
Nationwide in the USA.
Lot
Lots: 502H001 Exp. 01/2019; 502H003, 502H004, 502H005, Exp. 04/2019; 502H009, 502H012, Exp. 05/2019.
Risk classification
Class I
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was Piperacillin and Tazobactam for Injection, USP 4.5 gram/vial* 10-count Single Use Vials per carton, Rx only, Mfg. by: Hospira Healthcare India Pvt. Ltd. Irungattukottai-602 105, India Mfg. for: Apotex Corp. Weston, FL 33326. NDC 60505-0688-4 recalled?

Yes. FDA published recall D-0840-2018 on May 23, 2018. Reported hazard: Subpotent Drug: High Levels of Impurities Resulting in Decrease Potency

What should I do if I have this product?

Voluntary: Firm initiated · Letter